PR Newswire - Despite Availability of Numerous Generic Antidepressants, Forest Laboratories’ Lexapro Retains Leadership Among First-Line Therapies in the Treatment of Major…

The US Food and Drug Administration has approved the use of Forest’s Lexapro (escitalopram) for the treatment of generalized anxiety disorder.

Most Popular
5 Regular Mistakes In Public Speaking
3 Questions No Job Seeker Ever Wants To Be Asked?
Public Speaking: 7 Secrets Of Great Public Speakers
13 Job Interview Mistakes To Avoid
Public Speaking - Owning “The Skills” Part II

The decision was based on three randomized, double-blind, placebo-controlled eight-week studies involving around 850 patients aged 18-80 years. Subjects receiving Lexapro …
Want to read the whole article? You can purchase it here. It’s quick and easy.

source